BioSenic SA
BIOS | XBRU
Overview
Corporate Details
- ISIN(s):
- BE0970179827 (+1 more)
- LEI:
- 549300HFIIMTOP1DFR76
- Country:
- Belgium
- Address:
- RUE GRANBONPRÉ 11, 1435 MONT-ST-GUIBERT
- Website:
- http://www.biosenic.com/
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
BioSenic is an innovative company with the objective of addressing important unmet medical needs in the areas of innate immunity, inflammation and organ/function repair. Our expertise is focused on bone cell therapy and the therapeutic use of arsenic trioxide (As2O3). BioSenic aims to become a leading company in the field of regenerative and immune medicine by developing innovative products for bone and autoimmune and inflammatory diseases. BioSenic has a broad and diverse portfolio of solutions in clinical development in a variety of therapeutic areas targeting markets characterized by significant unmet medical needs and limited innovation.
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-03-31 07:00 |
Major Shareholding Notification
BIOS_PR_2025_March_Denominator_EN.pdf
|
English | 285.4 KB | |
| 2025-03-31 07:00 |
Major Shareholding Notification
BIOS_PR_2025_mars_Denominator_FR.pdf
|
French | 249.4 KB | |
| 2025-03-04 21:00 |
Regulatory News Service
BIOS_PR_20250304_EN.pdf
|
English | 275.4 KB | |
| 2025-03-04 21:00 |
Regulatory News Service
BIOS_PR_20250304_FR.pdf
|
French | 237.3 KB | |
| 2025-01-27 17:30 |
Declaration of Voting Results & Voting Rights Announcements
BIOS_PR_2025_January_Denominator_EN.pdf
|
English | 287.5 KB | |
| 2025-01-27 17:30 |
Declaration of Voting Results & Voting Rights Announcements
BIOS_PR_2025_janvier_Denominator_FR.pdf
|
French | 252.0 KB | |
| 2025-01-23 21:30 |
Declaration of Voting Results & Voting Rights Announcements
BIOS_PR_2024_December_Denominator_EN.pdf
|
English | 288.4 KB | |
| 2025-01-23 21:30 |
Declaration of Voting Results & Voting Rights Announcements
BIOS_PR_2024_décembre_Denominator_FR.pdf
|
French | 251.6 KB | |
| 2025-01-23 21:00 |
Regulatory News Service
BIOS_PR_2025-01-23_Transparency Notification_CGE_EN.pdf
|
English | 283.5 KB | |
| 2025-01-23 21:00 |
Major Shareholding Notification
BIOS_PR_2025-01-23_Transparency Notification_CGE_FR_.pdf
|
French | 249.7 KB | |
| 2025-01-03 00:00 |
Declaration of Voting Results & Voting Rights Announcements
BIOS_PR_03012025-EN.pdf
|
English | 318.0 KB | |
| 2025-01-03 00:00 |
Declaration of Voting Results & Voting Rights Announcements
BIOS_PR_03012025-FR.pdf
|
French | 274.6 KB | |
| 2024-12-13 00:00 |
Regulatory News Service
BioSenic - PR TrialCap (EN) - final.pdf
|
English | 242.5 KB | |
| 2024-12-13 00:00 |
Regulatory News Service
BioSenic - PR TrialCap - final.pdf
|
French | 280.9 KB | |
| 2024-10-31 18:00 |
Declaration of Voting Results & Voting Rights Announcements
BIOS_PR_2024_October_Denominator_EN_final.pdf
|
English | 283.5 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-08-16 | Rieger Francois | Board | Sell | 2,500,000 | 25,000.00 EUR |
| 2024-08-06 | Rieger Francois | Board | Sell | 868,653 | 7,186.87 EUR |
| 2024-08-05 | POMI SCHNEITER VERONIQUE | Board | Sell | 534,750 | 4,331.47 EUR |
| 2024-08-02 | POMI SCHNEITER VERONIQUE | Board | Sell | 193,900 | 1,609.37 EUR |
| 2024-08-01 | Rieger Francois | Board | Sell | 1,236,684 | 11,463.87 EUR |
| 2024-08-01 | POMI SCHNEITER VERONIQUE | Board | Sell | 140,003 | 1,246.03 EUR |
| 2024-07-31 | POMI SCHNEITER VERONIQUE | Board | Sell | 503,771 | 4,685.07 EUR |
| 2024-07-30 | POMI SCHNEITER VERONIQUE | Board | Sell | 360,021 | 3,348.20 EUR |
| 2024-07-29 | POMI SCHNEITER VERONIQUE | Board | Sell | 372,893 | 3,430.62 EUR |
| 2024-07-24 | POMI SCHNEITER VERONIQUE | Board | Sell | 2,168,361 | 21,033.10 EUR |
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
ANIMALCARE GROUP PLC | United Kingdom | ANCR | |
|
Annexin Pharmaceuticals AB | Sweden | ANNX | |
|
Apontis Pharma AG | Germany | APPH | |
|
Aptahem AB | Sweden | APTA | |
|
Arctic Bioscience | Norway | ABS | |
|
ArcticZymes Technologies | Norway | AZT | |
|
argenx SE | Netherlands (Kingdom of the) | 1AE | |
|
ARIX BIOSCIENCE PLC | United Kingdom | ARIX | |
|
AroCell AB | Sweden | AROC | |
|
Arterra Bioscience | Italy | ABS |